Why is Beta Drugs Ltd falling/rising?

As of 25-Sep, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,800.00, reflecting a decrease of 34.7 points or 1.89%. The stock has underperformed its sector today by 1.03% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has seen a return of -2.53%, and over the past month, it has declined by 6.19%. Despite a strong performance over the longer term, with a 139.25% increase over three years and an impressive 1844.32% rise over five years, the recent trends indicate a downturn. There is a notable increase in investor participation, with delivery volume rising by 54.26% compared to the 5-day average, suggesting some interest despite the price drop. However, no specific positive or negative factors were provided to further explain the recent movement.
Broader Market Context: In comparison to the benchmark, the Sensex has also shown a decline of 2.10% over the past week, indicating that the broader market is experiencing downward pressure as well. However, Beta Drugs Ltd's performance has been significantly worse than the benchmark in the short term, with a larger percentage decline. Year-to-date, while the stock has fallen by 5.69%, the Sensex has gained 5.27%, highlighting a stark contrast in performance between the stock and the broader market. This divergence suggests that while the market may be recovering, Beta Drugs Ltd is struggling to maintain its momentum.